Formulation Development Solutions
-
Trusted End-To-End CDMO Partner For Your Journey
In an increasingly competitive environment, working with the right CDMO is vital for successful drug lifecycle management. We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.
-
Early Development: Accelerating Molecules Through To Proof-Of-Concept
3/3/2022
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
A Quick Guide To Dissolution Testing
4/1/2022
What is dissolution testing? Why is it critical? What should you consider for your method validation? Find answers to these questions and more in this quick guide to dissolution testing.
-
Integrated Programs To Bridge Molecules From Discovery Into Clinical Development
1/4/2023
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Preparative Chromatography System Intended For Method And Process Development
6/3/2024
Available in two versions, ÄKTA avant systems have different flow rate/pressure specifications but share the same hardware setup.
-
Cutting-Edge Data Integration And Analytics Platform
11/26/2024
Genedata Profiler empowers biopharma R&D by integrating, harmonizing, and analyzing diverse data, enhancing collaboration, accelerating insights, and reducing costs for precision medicine advancement.
-
Psychedelics: Drug Development Capabilities
10/30/2023
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
Evolve The Future Of Cell Therapy Manufacturing
10/17/2022
Learn more about a closed, automated isolation and bead removal system for cell therapy manufacturing used to streamline and expedite your cell therapy development.
-
4Cell® NutriVero™ Flex 10 Medium
8/26/2022
A next generation chemically defined medium designed to support the growth of Vero cells and virus production.
-
Developability And Analytics
3/27/2025
Conducting early developability assessments is essential to identify potential risks and mitigate costly late-stage failures, ensuring the successful development of biologic therapeutics.